A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion Gene
Clinical trial NCT04395677 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04395677
- Sponsor
- Nuvation Bio Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-07
- Primary completion
- 2024-06-07
- Enrollment
- 173
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.